コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 so identified epitopes unique to each Dengue serotype.
2 d loops that differ in sequence depending on serotype.
3 age, sex, disease severity, and enterovirus serotype.
4 pecific antibody responses against each DENV serotype.
5 ere a pneumococcal conjugate vaccine (PCV13) serotype.
6 ed with the prevalence of resistance in that serotype.
7 (0.25-0.69) for that caused by 3, 6A and 19A serotypes.
8 ions in pneumococcal disease caused by these serotypes.
9 sal swabs, and (iii) the distribution of GBS serotypes.
10 ; 6 of the 21 MAbs neutralized three or more serotypes.
11 nd postbooster (D301) doses for pneumococcal serotypes.
12 vity from mouse sera immunized with parental serotypes.
13 highly penetrant viruses with cross-reactive serotypes.
14 the nucleolus do not colocalize for all the serotypes.
15 o process P1 polyproteins from multiple FMDV serotypes.
16 pneumococcal disease (IPD) caused by vaccine serotypes.
17 provide long-term immunity against all four serotypes.
18 a dangerous strain among 225 E. coli unique serotypes.
19 lly enhance infection by heterologous Dengue serotypes.
20 ver, mAb 2E8 recognizes NS1 of all four DENV serotypes.
21 ional antibody responses against all vaccine serotypes.
22 with representatives from the 4 major viral serotypes.
23 ined maternal and perinatal outcomes and GBS serotypes.
24 e in this region has been determined for all serotypes.
25 OPV) for outbreak response considering all 3 serotypes.
26 y was achieved on days 7, 28, and 56 for all serotypes.
27 children younger than 5 years caused by any serotype, 0.16 (0.07-0.40) for disease caused by PCV7 se
28 0.16 (0.07-0.40) for disease caused by PCV7 serotypes, 0.17 (0.07-0.42) for disease caused by 1, 5,
31 evolving murine antigenic epitopes on an AAV serotype 1 capsid template can evade NAbs without compro
32 tudy provides evidence that, within the same serotype 1 clonal complex, biological properties differ
33 tes) and Pakistan (Balochistan Province) and serotype 1 wild poliovirus in Pakistan, Afghanistan, and
34 (E1) specific for a potent, fully human DENV serotype 1-specific antibody, termed HM14c10, derived fr
36 ster than those given the 2 + 1 schedule for serotypes 1 (8.92 mug/mL vs 3.07 mug/mL), 4 (3.43 mug/mL
38 elope (E) protein of viruses of dengue virus serotypes 1, 2, and 3 targeted by human neutralizing ant
40 sessed at birth, day (D) 43, and D91 for GBS serotypes; 1 month postdose 3 (D127) for diphtheria; and
42 Using geolocated genotype (800 cases) and serotype (17,291 cases) data, we show that in Bangkok, T
48 deletion variant of the dengue virus (DENV) serotype 2 (DENV2) Tonga/74 strain lacking 30 nucleotide
49 by which several strains of human astrovirus serotype 2 (HAstV-2) are resistant to the potent HAstV-2
54 que variants of 3 pneumococcal strains, D39 (serotype 2), WCH43 (serotype 4) and WCH16 (serotype 6A)
55 f a recombinant adenoassociated viral vector serotype 2/5 (rAAV2/5) encoding human alpha-N-acetylgluc
61 ars not to affect cell wall shielding, since serotypes 33A and 33F exhibit comparable nonspecific ops
62 and adhesion to nasopharyngeal cells, though serotype 33F survived short-term drying better than sero
70 candidate, but due to their previous rarity, serotype 35B strains have not been scrutinized for under
75 e O-acetyltransferase WciG was functional in serotype 35C but nonfunctional in serotype 42 due to a d
76 presence of O-acetyltransferase genes in the serotype 35C cps locus suggested that it could be incomp
79 nal in serotype 42 due to a deletion in wciG Serotype 35C was O-acetylated at the 5- and 6-positions
83 ents, we assess the dynamics of dengue virus serotype 4 during the 2012 outbreak in Rio de Janeiro.
87 ctional in serotype 35C but nonfunctional in serotype 42 due to a deletion in wciG Serotype 35C was O
89 ion of serotype 35C from the closely related serotype 42 was unclear, as their reported cps loci are
90 of a codon-optimized adeno-associated virus serotype 5 (AAV5) vector encoding a B-domain-deleted hum
93 engineered RD and SC versions of adenovirus serotype 6 (Ad6) to express the hemagglutinin (HA) gene
99 idic linkage to PG was also demonstrated for serotypes 8 and 31, whose reducing end sugars are glucos
100 Overall, 132 isolates from fatal cases were serotyped (88%) and 35 distinct serotypes were identifie
101 specific tetracysteine sequence into the AAV serotype 9 (AAV9) capsid, to permit labelling of viral p
102 MIS, using either an adeno-associated virus serotype 9 (AAV9) gene therapy vector or recombinant pro
103 e dose of intravenous adeno-associated virus serotype 9 carrying SMN complementary DNA encoding the m
104 ac gene editing using adeno-associated virus serotype 9 to deliver a single short guide RNA is target
106 Using intrathecal adeno-associated virus serotype 9-based delivery, the glutamate-gated chloride
107 nd that prior in vivo Adeno-associated virus serotype 9-mediated gene delivery of GJA1-20k to the hea
108 AND Using an in vivo Adeno-associated virus serotype 9-mediated gene transfer system, we confirmed i
109 omplementary adeno-associated viral vectors, serotype-9 (scAAV-9) in spinal cord tissues after intras
110 icrobial-resistant sequence type 156 (ST156) serotype 9V S. pneumoniae in 3 respiratory patients that
114 e GD1a can associate to botulinum neurotoxin serotype A when expressed as individual trisaccharides.
115 inactivated FMDV serotypes (O, A, and Asia1 serotypes) a B cell response to FMDV SAT1 and serotype C
116 ploid isolates of C. neoformans var. grubii (serotype AA) and of hybrids with C. neoformans var. neof
117 hrough the investigation of 12 different AAV serotypes (AAV1 to -12), we find that AAP is not an esse
121 hybrids with C. neoformans var. neoformans (serotype AD) such aneuploidies have resulted in loss of
122 terval: 79-97%) and 80% (46-93%) for PCV7/13 serotypes among Bedouin and Jewish children <12 months o
126 shown the compatibility of capsids from AAV serotypes and homology of recognition sites of AAV Nab l
127 ine association between carried pneumococcal serotypes and respiratory viruses during childhood commu
131 2016, 13 468 (94.9%) were characterized with serotyping and 12 235 (86.2%) with antibiotic susceptibi
133 .07-0.42) for disease caused by 1, 5, and 7F serotypes, and 0.41 (0.25-0.69) for that caused by 3, 6A
135 ared to PCV7 serotypes, the additional PCV13 serotypes are more likely to cause bacteremic LRTI and e
137 UTR and P1 genomic region in all three Sabin serotypes, as well as vaccine-related viruses with multi
138 ccus pneumoniae serotype 35B is a nonvaccine serotype associated with high rates of penicillin nonsus
139 n MAbs (90.5%) neutralized at least one DENV serotype at concentrations of 1 mug/ml or less; 6 of the
141 on induced significant IgG responses for all serotypes: at day 30 compared with baseline, O1A titres
142 HCAECs were stimulated with purified Aa serotype b lipopolysaccharide (LPS) (Aa-LPS), heat-kille
143 r switching has occurred between MDR vaccine serotypes belonging to ST156 (e.g., 9V, 14, and 19A) and
146 cted from challenge with individual virulent serotypes, both in early challenge and after 5 months of
147 ociations exist between lineage and capsular serotype but these can be easily perturbed, such as by v
149 s (DENV), yet cross-reactivity with distinct serotypes can precipitate life-threatening clinical dise
151 gated the transduction efficiency of 12 rAAV serotypes carrying an enhanced green fluorescent protein
153 pe 2 wild poliovirus, 1 of 3 wild poliovirus serotypes causing paralytic polio since the beginning of
155 ng positive selection, the sequences of PorB serotypes commonly associated with invasive disease are
156 rs (6.1-16.6) for the grouped six additional serotypes contained in the 13-valent PCV (PCV13) but not
158 redible interval [CrI] 7.8-10.3) for grouped serotypes contained in the seven-valent PCV (PCV7), and
161 erum samples to estimate the contribution of serotype-cross-reactive and type-specific antibodies to
163 contrast, synapses fully intoxicated by BoNT serotypes D or E were refractory to synaptic rescue by a
171 , using liver-targeted adenoassociated virus serotype DJ/8 (AAV-DJ/8) in BTBR wild-type and BTBR Lep(
172 more colony-forming units per mL of vaccine-serotype E coli was noted in the vaccine compared with t
175 potentially acquire advantages from parental serotypes for enhancement of AAV transduction and evasio
177 as a critical entry receptor, different AAV serotypes have evolved distinctive interactions with the
179 h are constructed against the most prevalent serotypes, have caused great reductions in pneumococcal
180 a small-scale immunoisolation of the antigen serotypes HLA-A*02:01 and HLA-B*27:05 expressed on the E
183 ity assessment (EQA) scheme for pneumococcal serotype identification has been performed over a period
193 N: Our findings show that for nine of the 13 serotypes in PCV13, post-booster responses in infants pr
195 urinary antigen detection (UAD) assay for 13 serotypes included in the pneumococcal conjugate vaccine
197 duction of vectors derived from multiple AAV serotypes, including the evolutionarily distant serotype
198 r (AAVR) is a key host receptor for multiple serotypes, including the most studied serotype, AAV2.
200 ive pneumococcal disease caused by non-PCV13 serotypes increased, which suggests serotype replacement
201 gue virus NS5 also binds SLAs from different serotypes, indicating that NS5 recognizes the overall sh
202 of two or more doses of PCV13 against PCV13-serotype invasive pneumococcal disease was 85% (95% CI 3
203 data, the model-predicted changes in vaccine-serotype IPD incidence rates were similar to the observe
205 Of 701 accessory genes identified among dual-serotype IPD isolates, four were common between isolate
207 and find that the duration of carriage of a serotype is indeed positively correlated with the preval
215 reased production of SPN and SLO in epidemic serotype M1 and M89 S. pyogenes strains is associated wi
217 type-specific regulator mutations focuses on serotype M3 GAS isolates, and how the identified rewirin
219 fied rewiring of regulatory networks in this serotype may be contributing to a decades old epidemiolo
220 the isolates (n = 172) identified all 10 GBS serotypes, most commonly types Ia (40% [69/172 isolates]
223 tx1 or stx2 or were found to be positive for serotype O:157 when analyzed using alternative molecular
226 culation of three different inactivated FMDV serotypes (O, A, and Asia1 serotypes) a B cell response
228 e to Streptococcus pneumoniae, trends in the serotype of invasive pneumococci, and invasive pneumococ
232 s reduced cross-reactivity between different serotypes of dengue and also between a single-mutation a
233 infection or vaccination.IMPORTANCE The four serotypes of dengue virus are the causative agents of de
234 where conserved sequences present in all the serotypes of Dengue virus has been employed for fabricat
241 The introduction of a vaccine targeting 13 serotypes (PCV13) in 2010 has led to concern that this s
242 ormally sterile body fluids, reconfirmed and serotyped pneumococcal isolates, and established antimic
243 nd provides a national reference service for serotyping pneumococcal isolates in England and Wales.
244 pisodes historically associated with vaccine-serotype pneumococci may impact the susceptibility of ch
256 accine-targeted and non-vaccine pneumococcal serotypes showed lower rates of progression to complex O
260 ycoconjugate GBS vaccine elicited higher GBS serotype-specific antibody levels in infants until 90 da
261 ruited to the study (n=40 [20%]), functional serotype-specific antibody was similar between schedules
262 he first few weeks of life, whereas maternal serotype-specific anticapsular antibody is associated wi
263 kinetics of transplacentally transferred GBS serotype-specific capsular antibodies in the infants and
265 d indirect effectiveness of PCV by analyzing serotype-specific colonization prevalence and IPD incide
266 to -12 are all localized in the nucleus with serotype-specific differential patterns of nucleolar ass
267 led understanding of the fine specificity of serotype-specific human antibodies is vital for the deve
269 f the 5J7 quaternary epitope is a target for serotype-specific neutralizing antibodies after DENV3 in
274 ker region of seven residues in NS5, rich in serotype-specific residues, is important for the recover
276 NPs of adult C57BL/6 mice with S. pneumoniae serotype (ST) 6A or 8 and then coinfected them with mous
279 s been visualized at a conserved site in two serotypes suggesting a propensity for sulfated-sugar bin
280 ependent enhancement of Dengue-1, 2, 3 and 4 serotypes suggesting that pre-existing immunity to Zika
281 estimates appeared more balanced within each serotype, suggesting that genotype-level heterogeneity m
283 cell response are similar for all four FMDV serotypes tested following a homologous FMDV vaccination
284 V13) was designed to include disease-causing serotypes that are important in low-income and middle-in
285 bute to the very large numbers of rhinovirus serotypes that coexist while differing in virulence.IMPO
286 PCV failure is rare and, compared to PCV7 serotypes, the additional PCV13 serotypes are more likel
287 involvement of specific clones or O-antigen serotypes, the presence of certain horizontally acquired
288 Prevnar13 that contains CPS antigens from 13 serotypes undergo modifications or degradation during is
290 nce of capsid assembly processes of these 12 serotypes using combinatorial approaches that involved i
291 forming units per mL), the number of vaccine serotype UTIs did not differ significantly between group
295 l cases were serotyped (88%) and 35 distinct serotypes were identified, with no serotype predominance
300 scuous in promoting capsid assembly of other serotypes, with the exception of AAP4, -5, -11, and -12;
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。